patent-istock-579425600-duncan-andison

Duncan_Andison / iStockphoto.com

2 March 2017Americas

Federal Circuit affirms district court’s Bayer ruling

The US Court of Appeals for the Federal Circuit has partially affirmed a ruling by a district court in a patent dispute between Bayer and Dow Agrosciences.

Already registered?

Login to your account

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Federal Circuit denies further term extensions to shoulder surgery patentee

9 February 2021 The US Court of Appeals for the Federal Circuit has upheld a decision by a district court that an inventor cannot further extend his shoulder surgery patent after already being granted a term adjustment period by the US Patent and Trademark Office.

Federal Circuit denies CardiAQ injunction request against Neovasc

5 September 2017 The US Court of Appeals for the Federal Circuit has affirmed a district court decision which stated that CardiAQ is not entitled to injunctive relief, despite a $91 million damages payout from Neovasc.

More on this story

Federal Circuit denies further term extensions to shoulder surgery patentee

9 February 2021 The US Court of Appeals for the Federal Circuit has upheld a decision by a district court that an inventor cannot further extend his shoulder surgery patent after already being granted a term adjustment period by the US Patent and Trademark Office.

Federal Circuit denies CardiAQ injunction request against Neovasc

5 September 2017 The US Court of Appeals for the Federal Circuit has affirmed a district court decision which stated that CardiAQ is not entitled to injunctive relief, despite a $91 million damages payout from Neovasc.

More on this story

Federal Circuit denies further term extensions to shoulder surgery patentee

9 February 2021 The US Court of Appeals for the Federal Circuit has upheld a decision by a district court that an inventor cannot further extend his shoulder surgery patent after already being granted a term adjustment period by the US Patent and Trademark Office.

Federal Circuit denies CardiAQ injunction request against Neovasc

5 September 2017 The US Court of Appeals for the Federal Circuit has affirmed a district court decision which stated that CardiAQ is not entitled to injunctive relief, despite a $91 million damages payout from Neovasc.

More features

Chicago firm Much Shelist adds partner with ‘entrepreneurial mindset’

Powell Gilbert launches Düsseldorf office with leading patent litigator

Startups toolkit: Why investors want more than patents

J&J fends off generic schizophrenia drug bids

Kilpatrick adds ‘seasoned litigator’ as trademark partner

WATCH: An update on EPO Board of Appeal strategy for 2025 and beyond

Startup challenges rival over brain monitoring tech at ITC

UKIPO rejects Boehringer’s SPC for horse inhaler